Acuta Capital Partners as of March 31, 2019
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 32 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Iovance Biotherapeutics (IOVA) | 13.3 | $28M | 2.9M | 9.51 | |
Kadmon Hldgs | 9.6 | $20M | 7.6M | 2.64 | |
Assembly Biosciences | 7.1 | $15M | 761k | 19.69 | |
Biohaven Pharmaceutical Holding | 6.3 | $13M | 256k | 51.47 | |
CAS Medical Systems | 6.1 | $13M | 5.3M | 2.43 | |
Insmed (INSM) | 5.1 | $11M | 370k | 29.07 | |
Immunomedics | 4.6 | $9.6M | 500k | 19.21 | |
Veracyte (VCYT) | 4.5 | $9.5M | 382k | 25.02 | |
Dermira | 4.1 | $8.6M | 637k | 13.55 | |
Argenx Se (ARGX) | 3.8 | $7.9M | 64k | 124.83 | |
Cymabay Therapeutics | 3.3 | $6.9M | 518k | 13.28 | |
Viewray (VRAYQ) | 2.9 | $6.0M | 815k | 7.39 | |
Kalvista Pharmaceuticals (KALV) | 2.8 | $5.9M | 206k | 28.62 | |
Enanta Pharmaceuticals (ENTA) | 2.8 | $5.8M | 61k | 95.52 | |
Xenon Pharmaceuticals (XENE) | 2.7 | $5.6M | 553k | 10.16 | |
IRIDEX Corporation (IRIX) | 2.5 | $5.4M | 1.2M | 4.56 | |
Dicerna Pharmaceuticals | 2.3 | $4.8M | 329k | 14.65 | |
Adverum Biotechnologies | 2.3 | $4.8M | 919k | 5.24 | |
Arvinas Ord (ARVN) | 2.2 | $4.6M | 314k | 14.76 | |
Protagonist Therapeutics (PTGX) | 2.0 | $4.2M | 338k | 12.57 | |
Alector (ALEC) | 1.8 | $3.7M | 200k | 18.72 | |
Acer Therapeutics | 1.7 | $3.6M | 147k | 24.30 | |
Arrowhead Pharmaceuticals (ARWR) | 1.5 | $3.1M | 168k | 18.35 | |
Mirati Therapeutics | 1.4 | $3.0M | 41k | 73.29 | |
Quotient | 1.2 | $2.5M | 280k | 9.01 | |
Amarin Corporation (AMRN) | 0.9 | $1.8M | 88k | 20.77 | |
Gossamer Bio (GOSS) | 0.6 | $1.3M | 60k | 21.67 | |
Allakos (ALLK) | 0.3 | $547k | 14k | 40.52 | |
Sutro Biopharma (STRO) | 0.2 | $518k | 46k | 11.38 | |
Chembio Diagnostics | 0.1 | $231k | 42k | 5.54 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $204k | 25k | 8.16 | |
Novavax | 0.1 | $138k | 250k | 0.55 |